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Abstract
Ubiquitination is a reversible protein modification that influences various cellular processes in eukaryotic cells.
Deubiquitinating enzymes remove ubiquitin, maintain ubiquitin homeostasis and regulate protein degradation via the
ubiquitination pathway. Cryptococcus neoformans is an important basidiomycete pathogen that causes life-threatening
meningoencephalitis primarily in the immunocompromised population. In order to understand the possible influence
deubiquitinases have on growth and virulence of the model pathogenic yeast Cryptococcus neoformans, we generated
deletion mutants of seven putative deubiquitinase genes. Compared to other deubiquitinating enzyme mutants, a ubp5D
mutant exhibited severely attenuated virulence and many distinct phenotypes, including decreased capsule formation,
hypomelanization, defective sporulation, and elevated sensitivity to several external stressors (such as high temperature,
oxidative and nitrosative stresses, high salts, and antifungal agents). Ubp5 is likely the major deubiquitinating enzyme for
stress responses in C. neoformans, which further delineates the evolutionary divergence of Cryptococcus from the model
yeast S. cerevisiae, and provides an important paradigm for understanding the potential role of deubiquitination in virulence
by other pathogenic fungi. Other putative deubiquitinase mutants (doa4D and ubp13D) share some phenotypes with the
ubp5D mutant, illustrating functional overlap among deubiquitinating enzymes in C. neoformans. Therefore,
deubiquitinating enzymes (especially Ubp5) are essential for the virulence composite of C. neoformans and provide an
additional yeast survival and propagation advantage in the host.
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Introduction
Cryptococcus neoformans is a very important basidiomycete fungal
pathogen, which can cause life-threatening meningoencephalitis
primarily among immunocompromised hosts. It has been
estimated that there are over 1 million new cases of cryptococcal
infection in HIV-infected patients each year, and approximately
625,000 deaths are associated with cryptococcal meningoenceph-
alitis [1]. Furthermore, cryptococcosis has also become one of
most common invasive fungal infections in patients with solid
organ transplantations or other immunosuppressive conditions [2].
Finally, an outbreak of cryptococcal disease among immunocom-
petent humans and animals on Vancouver Island and the Pacific
Northwest, USA since 1999 caused by Cryptococcus gattii (a species
that is closely related to C. neoformans) emphasizes that this infection
can break out of the classic opportunistic risk groups [3].
Undoubtedly, cryptococcosis has become a major pathogenic
burden on human health.
Cryptococcus can overcome various hostile conditions in vivo
(such as high temperature, oxidative and nitrosative stresses,
nutrient starvation, hypoxia, and high CO2) to produce disease
[4,5]. Several pathogenic factors contribute to the rapid adapta-
tion of Cryptococcus neoformans inside the mammalian host and have
been genetically characterized, including its polysaccharide
capsule [6], melanin [7], ability to grow at 37uC [8], urease [9],
and phospholipase [10] . In addition, substantial progress has been
made in understanding the signal transduction pathways regulat-
ing virulence and sexual reproduction over the last decade
[11,12,13]. Due to its well-defined sexual cycle, robust animal
models and molecular biology tools, C. neoformans has become an
excellent model for the study of fungal pathogenesis [14,15].
However, these advances have confirmed the fact that fungal
virulence is a very complicated phenotype. Identification of the
essential complex regulatory mechanisms in control of the
cryptococcal virulence composite and its networks will be helpful
in identifying targets to abrogate disease caused by C. neoformans.
Ubiquitination is an essential posttranslational modification of
cellular proteins in eukaryotic cells, which marks certain proteins
for degradation by the proteasome and thus is a major regulator of
protein activity and/or localization. Besides ubiquitin and the
proteasome, the ubiquitin pathway also includes multiple enzymes
such as E1 (ubiquitin activating enzyme), E2 (ubiquitin conjugat-
ing enzyme), E3 (ubiquitin ligase), and the DUBs (deubiquitinating
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series of reactions, in which ubiquitin is activated first by E1,
transferred to E2, and finally recognizes and tags specific substrate
proteins for degradation via the proteasome with the help of E3.
DUBs not only process the ubiquitin precursors into mature
monomers, but also help to re-utilize ubiquitin by cleaving it from
the substrate before targeted protein degradation. The ubiquitin-
proteasome system plays a central role in a variety of cellular
processes such as cell cycle progression, signal transduction,
transcriptional control, DNA repair, and stress responses [17,18].
DUBs belong to a highly-conserved protease superfamily that
can be divided into five subclasses based on their catalytic domain
structure: Ubiquitin C-Terminal Hydrolases (UCHs), ubiquitin-
specific proteases (USPs), ovarian tumor proteases (OTUs), JAB1/
MPN/Mov34 metalloenzymes (JAMMs) and Machado-Joseph
disease proteases [19,20]. A large number of DUB genes have
been discovered in eukaryotes (including approximately 19 in
S. cerevisiae,2 2i nSchizosaccharomyces pombe, and 95 in the human
genome), thus demonstrating their essential functions [20,21]. In
addition to maintaining ubiquitin homeostasis, DUBs also play
important roles in proofreading some specific ubiquitinated
substrates and rescuing them from proteolysis or the non-
degradative pathway [19].
In the last few years, significant progress has been made in
understanding the structures and biological functions of DUBs in
S. cerevisiae, S. pombe and humans [22,23,21]. In S. cerevisiae, DUBs
participate in regulating energy metabolism, sexual reproduction,
as well as various stress responses [24,25,26,27,28]. For example,
Doa4 and Ubp10 regulate the utilization of carbon and nitrogen
sources, respectively [24,27]. Deletion of UBP14 leads to
decreased meiotic efficiency, and a doa4D mutant shows a
sporulation defect [25]. Most DUBs in S. cerevisiae are generally
involved with the regulation of different stress responses
[26,29,28]. It is noteworthy that the DUB-encoding gene UBP15
not only regulates the stress response due to temperature changes
and chemical stresses, but also plays important roles in the growth
rate and cell size of S. cerevisiae [29,30,31]. Recently, studies have
suggested that DUBs take part in pathogenesis of C. neoformans via
regulating various stress responses and melanization [32,33].
However, the networks and mechanisms of deubiquitinating
enzymes as major controllers of the fungal virulence composite
remain to be further understood.
In this study, we use C. neoformans as a model to investigate the
role of the deubiquitinating enzyme family on fungal pathogenesis.
We found that deletion of the putative DUB-encoding gene UBP5
resulted in severely attenuated virulence and many distinct
phenotypes, encompassing not only the defects in the classical
pathogenicity factors such as capsule production and melanin
synthesis, but also elevated sensitivity to several other important
biological stresses and showed slower growth. In addition, we also
confirmed that Ubp5 influences the sexual reproduction of this
yeast. Our work illustrates the central importance of UBP5 in
adapting to hostile growth environments including infection sites
in the host, and highlights the divergence of this yeast from other
eukaryotes in the evolution of the DUB enzymes.
Results
Identification of DUB Homologues in C. neoformans
In order to identify genes important for maintenance of
infection and survival in the central nervous system (CNS), we
performed comparative transcriptional profiling experiments using
WT strain H99 and previously described mutant strains during
growth in ex vivo cerebrospinal fluid (CSF) and serum, and during
human or rabbit infection. As shown in Table S2, 17 genes
putatively involved in the ubiquitin-proteasome system were
identified as being differentially expressed in these conditions.
Therefore, to appreciate the function of this in vivo regulated
ubiquitination system, we focused on the importance of deubiqui-
tinating enzymes (DUB) in C. neoformans disease.
We identified 19 putative DUB proteins in the C. neoformans
strain H99 genome belonging to four of five DUB subfamilies
(UCH, USP, OTU, and JAMM) by homology to known DUBs
from S. cerevisiae and S. pombe. Of these, 12 have been previously
described via signature-tag mutagenesis and their roles in
Cryptococcus pathogenesis have been ascertained [32]. We deleted
two of these putative virulence-related DUB genes, DOA4 and
UBP14, in the WT strain H99 for use as controls in this study. Five
of the remaining seven uncharacterized putative DUBs were
deleted in the current study: Ubp5 (CNAG_05650), Ubp7
(CANG_03872), Ubp13 (CANG_01377), Otu1 (CANG_06428)
and Rpn11 (CANG_07028). Of the two remaining genes (UCH2,
CNAG_00989; UBP10, CNAG_01614), one (UCH2) may be an
essential gene as we are unable to obtain a null mutant strain after
numerous attempts. In contrast, putative null mutants of UBP10
exhibit unusual cell morphology and have not been further
characterized.
Bioinformatic analysis of the putative cryptococcal DUB
proteins in this study showed that five of them belong to the
USP subfamily (the largest one in C. neoformans includes 15 DUBs),
while the other two belong to either the OTU or JAMM
subfamilies. Many of these DUBs have amino-terminal extensions
while some have carboxyl-terminal extensions (Figure 1A). Even
within the same subfamily, their catalytic domains exhibit
significant differences in length, suggesting that there must be
different insertions in the catalytic domains of many isoforms.
Previous studies have confirmed that DUBs do display specificity
for both substrates and particular ubiquitin chain types, yet they all
share the basic role of cleaving off ubiquitin from other adduct or
fusion proteins [34,20,21]. These extensions and insertions may
contribute to the functional diversity of the DUB enzymes.
Interestingly, we found that deletion of UBP5 generated many
intriguing phenotypic changes in C. neoformans that were linked to
virulence. Therefore, we focused in detail on UBP5 for its
relationship to pathogenesis.
We compared protein sequences of CNAG_05650 and Ubp5
orthologs from different eukaryotic species. Sequence analysis
indicated that CNAG_05650 encodes 1113 amino acids in
multiple domains, including an N-terminal MATH domain (the
Meprin And TRAF-Homology domain, E-value: 3.4e-06), a UCH
domain (Ubiquitin carboxyl-terminal hydrolase, E-value: 3.8e-59),
and a C-terminal USP7 domain (Ubiquitin-specific protease 7, E-
value:2.4e-12) (Figure 1A). Domain arrangement was similar to
S. cerevisiae deubiquitinating enzyme Ubp15 with 38%, 54% and
44% identity in the three domains. An alignment of C. neoformans
CNAG_05650 with orthologs from other eukaryotic species
revealed conservation in protein domain structure (Figure 1B &
1C).
Characterization of DUB Roles in Stress Responses
To investigate the roles of deubiquitinating enzymes in growth
and virulence of C. neoformans, seven DUB genes were deleted in
the serotype A strain H99 (Table 1). Targeted disruption was
confirmed by PCR and Southern hybridization. Subsequently, we
reconstituted the ubp5D mutant to WT via ectopic integration of
the WT gene, and all the phenotypes shown for the ubp5D mutant
were complemented in the ubp5D+UBP5 reconstituted strain.
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regulating stress responses in eukaryotes [33], we tested the
sensitivity of each mutant to a variety of in vitro stresses. Unlike
the WT and other DUB mutant strains, only the ubp5D mutant
exhibited temperature sensitivity (ts), with a partial growth defect
at 37uC and complete growth inhibition at 39uC (Figure 2A). The
ts phenotype was not rescued by the addition of 1 M sorbitol (data
not shown) as was observed for a C. neoformans tps1D mutant that is
also thermosensitive [35]. Moreover, deletion of UBP5 resulted in
slower growth compared to WT even in rich medium at 30uC
(Figure 2A and Figure S1). To examine whether this poor growth
phenotype was due to carbon source preference, we also compared
its growth using different carbon sources (YP agar medium with
3% galactose, 3% lactate, 3% glycerol, and 2% raffinose). No
growth improvement was observed when the ubp5D strain grew in
the media with alternate carbon sources (data not shown).
The ubp5D mutant also showed increased sensitivity to H2O2
(2 mM) and NaNO2 (0.75 mM), whereas the other DUB mutants
exhibited no differences in sensitivity compared to the WT strain
(Figure 2B). Likewise, the ubp5D mutant showed increased
sensitivity to 1.5 M NaCl and 1.5 M KCl compared to WT,
whereas the doa4D mutant exhibited increased sensitivity to
elevated NaCl concentrations only (Figure 2C). Additionally, the
ubp5D mutant showed increased sensitivity to 0.02% SDS, 0.1%
caffeine or 0.5% congo red, whereas the doa4D mutant displayed
increased sensitivity to 0.02% SDS and 0.1% caffeine (Figure 2D).
To further appreciate the impact of DUB enzymes on specific
stress responses, all the mutants were exposed to various antifungal
drugs: amphotericin B, caspofungin, fluconazole, or flucytosine. In
vitro susceptibility testing was determined at 30uC according to the
Clinical and Laboratory Standards Institute broth microdilution
reference method (NCCLS, 2002). We observed that only the
ubp5D mutant was hypersusceptible to all four antifungal agents
compared with the WT strain, exhibiting an 8-fold reduction in
MIC for flucytosine, 4-fold reduction in MICs for both fluconazole
and caspofungin, and 2-fold reduction in MIC for amphotericin B
(Table 2). The ubp5D+UBP5 reconstituted strain completely
restored WT sensitivity to the four antifungal drugs. Among the
other DUB mutants, both the doa4D and ubp13D mutants showed
increased susceptibility to fluconazole and caspofungin, but not to
amphotericin B or flucytosine.
Following exposure to external stressors, misfolded or damaged
proteins trigger activation of the ubiquitin-dependent proteolytic
pathway. Maintenance of a sufficient ubiquitin pool is essential for
this process, and ubiquitin homeostasis is at least partly maintained
by the activity of DUB enzymes [19]. To understand the
relationship between UBP5 deletion and ubiquitin stasis, we
performed RT-PCR to examine the expression of UBI4 (encoding
polyubiquitin) in both ubp5D mutant and WT strains. UBI4
Figure 1. Structure analysis of deubiquitinating enzymes. A. Domain structure of cryptococcal deubiquitinating enzymes. 7 DUB enzymes in
this study belong to three subfamilies (USP, OTU, and JAMM) on the basis of their catalytic domains. USP and OTU domain DUBs are cysteine
proteases, JAMM domain DUB is metalloprotease. We retrieved domain architectures for each DUB using the Pfam databases (http://pfam.sanger.ac.
uk/). B. Comparison of Ubp5 orthologs between C. neoformans and other species. Each Ubp5 ortholog diagram shows functional protein domains,
which were identified by the Pfam database. C. Phylogenetic tree analysis of Ubp5 orthologs is depicted by Clustal W alignment from DNASTAR
software (versions 6.13). Protein sequences of Ubp5 orthologs were retrieved from the following database: C. neoformans Ubp5 (CNAG_05650) from
the C. neoformans var. grubii H99 database of the Broad Institute, and its orthologs among other eukaryotic species from the protein databank of
NCBI website. Cn, Cryptococcus neoformans; Um, Ustilago maydis; Sp, Schizosaccharomyces pombe; Sc, Saccharomyces cerevisiae; Ca, Candidia albicans;
Af, Aspergillus fumigatus; Ce, Caenorhabditis elegans; Dm, Drosophila melanogaster; Hs, Homo sapiens.
doi:10.1371/journal.pone.0038326.g001
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or reconstituted cells (Figure S3). Furthermore, deletion of UBP5
led to greatly elevated UBI4 expression at 37uC that peaked after
1 hr and then gradually declined. WT cells showed a gradual
increase in UBI4 expression at 37uC but its peak value was still
significantly lower than that in ubp5D cells, suggesting that UBP5
deletion may contribute to an increasing demand for polyubiquitin
in C. neoformans cells to cope with high temperature and/or other
stresses.
Taken together, deubiquitinating enzymes (especially Ubp5)
appear to play important roles in regulating various stress
responses. Deletion of Ubp5 made cryptococcal cells more
susceptible to nearly all in vitro stresses that are closely related
to pathogenesis compared to other DUB mutants. Therefore, we
predicted that Ubp5 would play important roles in regulating
pathogenesis of C. neoformans. Interestingly, phenotypes of several
DUB mutants under stress conditions demonstrated both func-
tional overlap and divergence within the deubiquitinating enzyme
family for these pathogenic responses.
Roles of DUBs in Capsule, Melanin and Urease Production
in C. neoformans
Several pathogenic factors are essential for C. neoformans to
invade the host, such as capsule, melanin, and urease. When
incubated under capsule-inducing conditions for 72 hrs, an
obvious capsule defect was observed for the ubp5D mutant,
whereas the reconstituted strain and other DUB mutants all
showed WT capsule production (Figure 3A). In order to exclude
the confounding effect of thermosensitivity, the ubp5D mutant was
also examined in capsule-inducing medium at 30uC. Similarly,
about 90% of ubp5D mutant cells displayed a significantly reduced
capsule while 10% produced capsule similar to WT (data not
Table 1. Strains and plasmids used in this study.
Strain and Plasmid Genotype Reference
C. neoformans
H99 MATa [98]
KN99a MATa [101]
DF001 MATaubp5::NEO This study
DF002 MATa ubp5::NAT This study
DF003 MATaubp5::NEO+ UBP5::NAT This study
DF004 MATadoa4::NAT This study
DF005 MATaubp7::NEO This study
DF006 MATaubp13::NEO This study
DF007 MATa ubp14::NAT This study
DF008 MATaotu1::NEO This study
DF009 MATarpn11::NEO This study
DF010 MATa::NAT This study
TOC4 MATarim101::nat RIM101::NEO [88]
ure1D MATaure1::ADE2 [9]
cap59D MATacap59::HYG [101]
Plasmid
pJAF1 NEO resistance gene [88]
pCH233 NAT resistance gene [88]
pUBP5-NAT Modified pCH233 containing gene
UBP5
This study
doi:10.1371/journal.pone.0038326.t001
Figure 2. UBP5 is involved in various stress responses of C. neoformans. A. Temperature sensitivity at 30uC, 37uC,39uC. B. Oxidative and
nitrosative stress assay. C. High salts and osmotic stress assay. D. Cell-wall and cell-membrane stress assay. Strains were grown to saturation at 30uCi n
liquid YPD medium, 10-fold serially diluted (1–10
6 dilutions), and spotted 3 ml cells on YPD or YNB agar (containing different stress-inducing agents).
Incubated them for five days and then photographed.
doi:10.1371/journal.pone.0038326.g002
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diameter/total diameter) for the WT, ubp5D and ubp5D+UBP5
strains, and found that the volume of the ubp5D capsule was
significantly smaller than WT (P,0.001) (Figure 3B). These data
were confirmed using an independent measurement of capsule
volume based on packed-cell volume (Figure 3C).
Since C. neoformans capsule is excreted from the cell via
exocytosis for attachment to the cell wall [36], a small proportion
of ubp5D mutant cells with similar capsule like WT suggested that
Ubp5 might not actually regulate capsule synthesis, but instead
regulate attachment. Therefore, a capsule transfer assay was also
performed [37]. Conditioned medium (CM) was prepared as a
source of capsule polysaccharide by growing WT and ubp5D
mutant cells in DMEM medium for one week; CM from acapsular
cells (cap59D) was used as a negative control. Indirect immuno-
fluorescence showed that acapsular cells could attach the capsular
polysaccharide from the ubp5D CM medium (Figure 3D). There-
fore, the ubp5D mutant synthesized capsule but was defective in
extracellular assembly of the capsule on the cell surface.
Melanin is another classic virulence factor in C. neoformans [38].
We assessed melanization for each of the DUB mutants on DOPA
medium at both 30uC and 37uC. The ubp5D mutant strain
exhibited hypomelanization on melanin-inducing medium at
30uC, and this defect was exacerbated at 37uC (Figure 4).
However, hypomelanizaion in three other DUB mutants (doa4D,
ubp13D and ubp14D) occurred at 37uC, suggesting that these
deubiquitinating enzymes also influence melanization at mamma-
lian host temperature. Copper availability is a major factor
influencing melanization in C. neoformans. Loss of several genes
related to copper ion metabolism (such as CCC2, ATX1 and CUF1)
result in melanin defects in cryptococcal cells [39,40], and many
studies in Saccharomyces suggest that copper homeostasis is
influenced by the ubiquitin system [41,42]. Therefore, we
hypothesized that DUBs might regulate melanization through
their interaction with copper metabolism. We analyzed the
melanization defect of the four DUB mutants by addition of
exogenous CuSO4 and by chelation of copper ions from the media
using bathocuproinedisulphonic acid (BCS). When copper ions
were added into DOPA medium, melanin production was restored
in all four DUB mutants (Figure 4B). However, after removing
copper from DOPA medium, the doa4D and ubp13D mutant
strains displayed completely non-melanized colonies whereas the
ubp5D and ubp14D strains exhibited merely decreased melaniza-
tion. Therefore, Ubp5 and Ubp14 may influence melanization by
other mechanisms in addition to their influence on copper ion
metabolism.
Urease is another important virulence factor of C. neoformans,
which promotes increased CNS invasion and non-protective
immune responses during lung infection [43,44]. When incubated
under Christianson’s urea agar, all the DUB mutants displayed
WT urease activity as measured by the medium color change from
yellow to bright pink (Figure S2). Therefore, these DUB enzymes
do not influence urease activity.
Ubp5 is Required for Sexual Reproduction of C.
neoformans
The UBP5 deletion was performed in both C. neoformans H99
(MATa) and KN99a (MATa) strain backgrounds. Sexual devel-
opment and production of dikaryotic hyphae and basidiospores
were examined in both unilateral crosses (ubp5D 6 WT) and
bilateral crosses (MATa ubp5D 6MATa ubp5D). Interestingly, no
hyphae nor basidiospores were observed in unilateral crosses after
two weeks co-incubation with mating partners (Figure 5A). In
order to eliminate the effect of decreased growth rate on mating,
we repeated the unilateral cross tests with a minor modification,
mixing ubp5D and WT cells at 10:1 ratio, and the result was still
negative (data not shown) indicating that a single copy of UBP5 is
insufficient to allow mating in C. neoformans.
To identify where the defect in sexual reproduction occurred,
we also performed a cell fusion assay. For this assay, strain DF001
(MATa ubp5D NEO) was mated with either strain DF002 (MATa
ubp5D NAT) or DF010 (MATa NAT) on V8 agar for 24 h or 72 h
and then plated on double selective medium (YPD containing
neomycin and nourseothricin). We observed that ubp5D strains did
not form colonies in bilateral crosses, suggesting Ubp5 is absolutely
required for cell fusion (Figure 5B). We also tested fusion in
unilateral crosses between ubp5D and WT; lack of viable colonies
from this mating indicates that UBP5 in each mating partner is
necessary for cell fusion (data not shown). This is consistent with
cpk1D, ste7D, and ste11D mitogen-activated protein kinase (MAPK)
pathway mutants, which also exhibit defects in fusion in unilateral
crosses [45].
Table 2. In vitro susceptibility of mutant strains to four antifungal agents.
MIC80(mgm l
21)
Antifungal compounds Amphotericin B Fluconazole Flucytosine Caspofungin
H99 0.5 8 16 32
ubp5D 0.25 2 2 8
ubp5D+UBP5 0.5 8 16 32
doa4D 0.5 4 16 16
ubp7D 0.5 8 16 32
ubp13D 0.5 4 16 16
ubp14D 0.5 8 16 32
otu1D 0.5 8 16 32
rpn11D 0.5 8 16 32
ATCC22019 0.5 2 0.125 0.5
The MICs of four antifungal agents against C. neoformans WT, DUB mutants and reconstituted strains were determined by the Clinical and Laboratory Standards
Institute broth microdilution refercence method (NCCLS, 2002), and Candida parapsilosis strain (ATCC22019) was used as a quality control strain.
doi:10.1371/journal.pone.0038326.t002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38326Figure 3. Disruption of UBP5 significantly down-regulates the capsule production. A. ubp5D mutants have a capsule defect. The WT strain
H99 and all the DUB mutants were cultured on DME medium for capsule production at 37uC for 3 days. Capsule was assessed by staining with India
ink and visualizing at 100 magnification (scale bar = 10 mm). B. Relative capsule volume detection. Total (cell and capsule) and cell-only diameter
were measured via Photoshop Software for 50 cells for each strain. Then calculated the relative ratio of capsule with the formula ([Total Volume-
Packed Volume]/Total Volume). After statistical analysis, the capsule production of ubp5D strain (7.760.48%) significantly decreased compared with
either WT (43.466.41%) or reconstituted strain (37.468.01%) (P,0.001). C. Cryptocrit for Capsule Assay. After overnight growth, each culture was
inoculated into tissue culture flasks with 20 mL DMEM medium in capsule-inducing condition for three days. Cells were killed with 10% formalin (V/V)
for 5 minutes, and then counted. The samples were standardized to 3.2610
8 cells/mL. The difference between ubp5D (21.2863.00) and
complemented (42.860.84) or WT (35.861.48) strains was P,0.001. D. Capsule transfer assay. Capsule material secreted from wild-type or ubp5D cells
into conditioned medium (CM) can be attached to acapsular acceptor cells (cap59D). cap59D cell cannot shed capsule polysaccharide, thus its CM was
used as a negative control. Cells were labeled with monoclonal antibody mAb18B7 and Alexa Fluror anti-mouse IgG (secondary antibody) was used
for immunofluorescence.
doi:10.1371/journal.pone.0038326.g003
Figure 4. Melanin production assay of DUB mutants in C. neoformans. A. Melanin production assay. Strains were grown on L-DOPA medium
alone at 30uC and 37uC. B. Regulation of melanization by copper availability. Mutants strains with hypomelanization were incubated onto DOPA agar
containing + 10 mM CuSO4, or containing + 1 mM BCS, a copper chelator at 37uC.
doi:10.1371/journal.pone.0038326.g004
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and are induced by nutritional limitation and co-incubation with
MATa cells [46]. MFa induction was assessed by real-time PCR in
WTa and ubp5Da mutant strains alone, and in mixed cell
populations of unilateral and bilateral crosses. After 24 h co-
culture with WT MATa cells, a dramatic induction of the MFa
pheromone gene occurred in the WT MATa strain (Figure 5C)
consistent with a previous report [46]. In contrast, when ubp5Da
mutant cells were co-incubated with WT or ubp5D mutant MATa
cells, MFa expression showed no induction (Figure 5C). In
addition, MFa transcription induced by limited nutrition alone
was slightly higher in the ubp5D mutant than in WT. These results
indicate that Ubp5 plays a complicated role in pheromone
expression, which is not only required for induction of MFa
transcription during mating but also negatively regulates its
expression under nutrient-limited conditions.
Roles of DUBs on Cryptococcal Survival in Macrophages
C. neoformans is a facultative pathogen, which can proliferate in
both intracellular and extracellular environments [47]. Macro-
phages are primary professional phagocytes in the host, and also
important for mediating the dissemination of cryptococcal cells
from the lungs to the brain [48]. Therefore, we evaluated the DUB
mutants for their ability to survive inside macrophages. The ubp5D
and doa4D mutants exhibited significant reduction (87% and 92%,
respectively) in their intracellular survival after co-inoculation with
activated macrophages in DMEM for 24 hours, while other DUB
Figure 5. C. neoformans Ubp5 is required for mating. A. The ubp5D mutant is sterile in both unilateral and bilateral crosses. Reintroduction of
the wild-type gene restores mating to a wild-type level. These fuzzy projections are mating-specific dikaryotic filaments. Mating assays were on V8
agar medium for 14 days at room temperature (scale bar = 10 mm). B. The ubp5D mutant is defective in cell fusion. Wild type cells (H99 and KN99a)
with different resistance genes (NEO and NAT) were set as a control. The MATa and MATa cells were mixed for 24 (WT strains) or 72 hours (ubp5D
mutant strains), serial diluted, and plated onto YPD argar containing both nourseothricin and neomycin. Following fusion, dikaryotic cells containing
both wild-type MATa and MATa cells were able to grow. However, no viable dikaryotic cells were on the double selective plate of ubp5D mutant. C.
MFa pheromone gene expression was assessed in a WT and ubp5D mutant strains alone, and in unilateral and bilateral crosses. Cells were incubated
on V8 mating medium for 24 h at room temperature. RNA was extracted, and MFa gene expression was detected by real-time PCR with primers MFa-
a/b (Table S1).
doi:10.1371/journal.pone.0038326.g005
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integration of UBP5 failed to restore intracellular survival in
macrophages in spite of restoring all in vitro phenotypes tested.
Multiple virulence factors of C. neoformans contribute to its
intracellular replication inside macrophages, including production
of capsule, melanin, and a variety of secreted enzymes
[49,47,50,51]. Obviously, lower intracellular survival of the ubp5D
mutant might result from a complex of several virulence-related
phenotypic changes such as capsule and melanin defects,
hypersensitivity to nitric oxide or hydrogen peroxide stress, slower
growth rate, as well as decreased thermotolerance. However, the
doa4D mutant exhibited significantly impaired intracellular
survival despite displaying WT phenotypes for many of these
virulence-related traits. Therefore, we hypothesize that Doa4 may
regulate intracellular proliferation of C. neoformans by as yet
additional undefined means.
Influence of Ubp5 on in vivo Virulence
Galleria mellonella is a useful non-vertebrate model for high-
throughput screening of in vivo virulence of C. neoformans
[52,53,54]. In order to assess whether deubiquitinating enzyme
deletions result in attenuated virulence, we employed a G. mellonella
survival assay to assess our seven DUB enzyme mutant strains.
Various degrees of virulence attenuation were observed in this
invertebrate model (Figure 7A). The ubp5D and doa4D mutants
showed a significant virulence attenuation: mean survival was
23.660.94 days for ubp5D (P,0.001) and 21.761.25 days for
doa4D (P=0.001) compared to 13.761.6 days for WT. In contrast,
the otu1D mutant exhibited hypervirulence (6.460.36d, P,0.001)
compared to WT strain (13.761.6d). None of the remaining
mutants exhibited altered virulence compared to WT. These
results are consistent with the macrophage killing assay, and both
assays illustrated that different DUB enzymes impact discrete
aspects of C. neoformans virulence despite their overarching
functional similarities.
The ability to survive at mammalian body temperature is
required for pathogenicity of C. neoformans; thermosensitive strains
are attenuated in the mammalian host. Since deletion of UBP5
impaired growth of C. neoformans at 37uC in vitro, we next assessed
the virulence of the ubp5D mutant in a murine inhalation model of
cryptococcosis. Female A/Jcr mice (10 per strain) were inoculated
per nasally with 10
5 CFU of the wild-type, ubp5D mutant, or
ubp5D+UBP5 reconstituted strains. Mice were monitored for
survival and sacrificed at predetermined clinical endpoints. In
contrast to the WT infected mice that exhibited complete
mortality by 22 days post-inoculation, none of ubp5D-infected
mice showed symptoms even after eight weeks post-infection,
demonstrating a major virulence defect (P,0.001) (Figure 7C).
Assessment of fungal burden in different organs showed that in
comparison to WT or reconstituted-strain infected mice, viable
cells were discovered from the lungs of mice infected by the ubp5D
mutant but not the spleens or brains. Clearly, the ubp5D mutant is
severely attenuated in the mammalian host for dissemination and
disease even though the mutant exhibited prolonged survival in
the lung. In contrast to the macrophage killing assay, reconstitu-
tion of UBP5 into the ubp5D mutant partially restored its virulence
in mice while completely restoring the G. mellonella virulence and
other in vitro phenotypes (Figure 7B and C).
UBP5 Deletion Effects on the C. neoformans
Transcriptome
To further gain insight into the molecular basis for the
pleiotropic phenotypes caused by UBP5 deletion, we carried out
a microarray analysis of the differential genome-wide transcription
profile of the ubp5gmutant versus its isogenic WT parental strain
under both ambient and elevated temperature (37uC). These
expression data have been submitted to the GEO database
(http://www.ncbi.nlm.gov/gds) under accession number
GSE35067. Among 10601 probes on the array, approximately
21% (1,463 genes) of the C. neoformans transcriptome showed
significantly different expression patterns in the ubp5gmutant
compared to the WT (P,0.05). Since the ubp5gmutant exhibited
decreased melanin production at 37uC, the transcriptional change
of the acid laccase-encoding gene CNM02420 (0.27-fold down-
regulation, P=5.82E-01) was selected as a reference cutoff.
Figure 6. Ubp5- and Doa4-mediated survival in macrophages. Activated J774A.1 macrophages were co-incubated with the WT, all the DUB
mutants and complemented strains of C. neoformans for 2 hours at 37uCi n5 %C O 2. Extracellular yeasts were then removed, and cocultures were
incubated overnight under the same conditions. Following co-incubation, macrophages were lysed via 0.05% SDS and viable C. neoformans colonies
were counted on YPD plates after 3–4 days’ growth at 30uC. Each strain was tested in triplicate (P ubp5D=0.003, P doa4D,0.001).
doi:10.1371/journal.pone.0038326.g006
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based on these criteria.
We specifically assessed how ubp5 mutation affects gene
transcription pattern in C. neoformans at 30uC. Genes regulated
by DUB enzyme Ubp5 deletion covered a wide variety of
functional categories (Table 3). First, a group of genes involved in
nutritional metabolism exhibited differential expression in the
ubp5g mutant compared to WT. Several enzymes in carbon
utilization (e.g. sorbitol, alcohol and fatty acid) and ion stasis (e.g.
sodium, calcium and iron) were up-regulated while a number of
nitrogen-metabolite transporters (e.g. ammonium, spermine and
urea) were repressed, suggesting that UBP5 deletion may alter
metabolic flux in C. neoformans. Furthermore, several genes
involved in stress defenses, such as CNAG_07836 (NAD binding
dehydrogenase), CNL03740 (catalase), SOD2 (manganese superox-
ide dismutase) [55], AIF1 (apoptosis-inducing factor) [56] and
QDR3 (Multidrug transporter of the major facilitator superfamily),
were differentially expressed by UBP5 mutation. Ubp5 inactiva-
tion also resulted in many up-regulated genes associated with cell
wall/membrane organization. This may partially explain the
increased susceptibility to multiple cell-wall stressors and antifun-
gal agents in the ubp5g mutant (Figure 2 and Table 2). Finally,
Ubp5 inactivation also led to differential expression of several
genes involved in several basic cellular processes such as DNA
replication, transcriptional regulation and cell cycle, and may
explain the decreased growth rate at 30uC.
We also examined gene expression at 37uC. Several novel
findings were obtained from this analysis (Table 4). First, more
genes involved in stress responses, such as TPS2, CNB02790
(alpha, alpha-trehalase), GST3 and GST6 (glutathione S-transfer-
ase) were differentially expressed at 37uC compared to 30uC.
Second, high temperature further inhibited some genes related to
virulence factors such as CAP64 (capsular-related protein) and
FET3 (acid laccase). In addition, a large number of genes involved
in nucleotide metabolism, RNA processing and modification,
ribosome synthesis and cell division exhibited significant reduction
in ubp5g at 37uC.
Discussion
Modification of proteins by ubiquitination is a critical regulatory
mechanism for various cellular processes. Proteomic studies
indicate that about 1/5?1/6 of all proteins (1,075) are modified
by ubiquitination in Saccharomyces [57]. Deubiquinating enzymes
(DUBs), which mediate the removal and processing of ubiquitin
from ubiquitin precursors, ubiquitin-protein conjugates, and
unanchored ubiquitin chains, play essential roles in protein
degradation by either the proteasome or other ubiquitin-depen-
dent processes for their help in recycling ubiquitin. A previous
cryptococcal study described the phenotype of 12 DUB gene
deletion mutants regarding the classic pathogenicity factors
(capsule production, melanin and high temperature growth) and
in vivo virulence in the CMO18 strain background [32]. On the
basis of that study and our own in vivo transcriptional analyses
that suggested importance of this pathway for the virulence
composite, we performed a comprehensive functional analysis of
the DUB family in the model pathogenic yeast C. neoformans.
Figure 7. In vivo virulence assay of DUB mutants in G. mellonella and mouse infection models. A. Screening assay of DUB mutant strains in
the larvae model revealed various degrees of virulence. B. Reconstituted strain (ubp5D+UBP5) completely restored the virulence in G. mellonella killing
assay. C. Deletion of Ubp5 exhibited significantly attenuated virulence in murine inhalation infection model.
doi:10.1371/journal.pone.0038326.g007
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Category Gene ID
*
Fold change
ubp5?/WT P value Functional annotation
*
Carbohydrate/amino acid
metabolism
CNAG_00269 1.80 8.30E-09 Sorbitol dehydrogenase
CNC05840 1.50 4.60E-07 Glycosyl hydrolase
CNAG_06035 1.49 2.00E-08 Alcohol dehydrogenase
CNC01140 1.38 3.00E-10 Lipase
CNB00370 1.29 1.80E-07 Fatty acid beta-oxidation-related protein
CNE01100 0.71 1.50E-09 long-chain-fatty-acid-CoA ligase
CND00530 0.72 8.90E-07 Urea transporter
CNC06440 0.70 4.80E-08 Inositol-3-phosphate synthase
CNJ02210 0.63 7.10E-07 Spermine transporter
CNJ02220 0.59 1.70E-09 Adenine nucleotide transporter, involved in beta-oxidation
of medium-chain fatty acid
CNJ01880 0.50 4.40E-09 Ammonium transporter (AMT2)
Cell wall/membrane
organization
CNE03150 2.73 7.00E-12 1,3-beta-glucanase, involved in cell wall beta-glucan
assembly (Exg1p)
CNE03240 2.54 2.00E-18 Chitin synthase (Chs7p)
CNAG_06031 1.82 2.00E-12 Beta-glucan synthesis-associated protein
CNAG_04270 1.54 1.80E-09 SNAP receptor, mediate membrane fusion
CNI02290 1.47 4.80E-08 Polysaccharide synthase (Cps1p)
CNF01800 1.45 4.70E-07 Chitin deacetylase
CNN00660 1.42 1.30E-08 Glucan 1,3 beta-glucosidase protein putative
Ion transport and
metabolism
CNL05450 2.30 8.00E-10 Sodium, inorganic phosphate symporter
CNAG_04337 1.65 1.00E-14 Cation diffusion facilitator
CNK01330 1.53 4.00E-11 Calcium ion transporter
CND00150 1.52 5.40E-09 Ferric chelate reductase (Fre7p)
CNE04050 1.43 2.00E-12 Iron ion transport-related protein
DNA replication and repair CNAG_04696 1.91 1.00E-13 DNA clamp loader
CNI04060 1.38 5.00E-10 Mitochondrial genome maintenance protein
CNN01100 0.73 1.10E-06 Telomere maintenance protein
CNN01650 0.62 4.70E-08 DNA dependent ATPase for DNA repair (Rad26p)
Transcriptional regulation CNK03060 1.43 8.40E-09 C2H2 zinc finger protein Zas1
CNAG_04403 1.43 9.80E-08 CCCH zinc finger protein
CNB03490 0.64 3.70E-08 Transcriptional regulator
Stress response CNAG_07836 1.94 2.00E-12 NAD binding dehydrogenase with oxidoreductase activity
CNAG_04521 1.47 3.70E-09 Apoptosis-Inducing Factor (Aif1p)
CNL03740 1.36 3.90E-07 Catalase
CNI01590 1.29 1.00E-08 Manganese superoxide dismutase (SOD2p)
CNL04910 0.66 1.10E-09 Multidrug transporter of the major facilitator superfamily (Qdr3p)
Signal pathway CND06250 1.43 5.80E-06 MAP kinase kinase kinase
CNAG_00802 1.39 3.90E-06 Calcineurin-binding protein (Cbp1p)
Cell cycle CNG01990 1.62 8.00E-11 G1/s-specific cyclin pcl1 (cyclin hcs26)
CNI01430 1.32 7.70E-06 Cyclin-dependent protein kinase regulator
Other CNE02820 1.59 1.30E-09 AFG1-family ATPase
CNAG_06009 1.53 1.10E-09 Cyclohydrolase
CNC02450 1.48 1.50E-06 Water channel
CNL04120 0.54 2.00E-10 Adenosylmethionine-dependent methyltransferase
*Gene ID and functional annotation obtained from NCBI database (http://www.ncbi.nlm.nih.gov/) or Broad database (http://www.broadinstitute.org/annotation/
genome/cryptococcus_neoformans/) with additional hand editing.
doi:10.1371/journal.pone.0038326.t003
Deubquitinating Enzyme Ubp5 in C. neoformans
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38326C. neoformans possesses 19 putative DUB genes among which most
appear to belong to the USP subfamily. In this report, we
disrupted five of the remaining deubiquitinase genes in the H99
strain background, along with the creation of two confirmed
virulence-related mutant strains (doa4D and ubp14D) in same
background for use as controls [32]. None of these genes were
essential and most DUB mutants did not exhibit significant growth
defects under standard growth conditions. However, deletion of
UBP5 led to severely altered phenotypes, which illustrates that this
deubiquitinating enzyme plays a vital but specific role in regulating
cell propagation, sexual reproduction, stress response and patho-
genesis of C. neoformans.
The first distinct phenotype in the ubp5gmutant is its poor
growth performance even in rich medium (Figure 2A) and
alternative carbon sources do not improve its growth (data not
shown). This observation may be partially contributing to the
Table 4. Ubp5p-dependent gene expressions at 37uC.
Category Gene ID
*
Fold change
ubp5?/WT P value Functional annotation
Carbohydrate/amino acid
metabolism
CNI00320 1.99 1.10E-07 Glyceraldehyde 3-phosphate dehydrogenase
CNE03150 1.53 7.60E-06 Cellulase (167.m03461)
CNA00470 1.52 1.10E-09 Fructose-bisphosphatase (181.m07830)
CNAG_02225 1.41 1.60E-08 Cellulase
CNF03760 1.40 2.30E-07 Carboxypeptidase C
CNN00510 1.37 2.50E-08 L-fucose permease
CNG01150 0.73 4.70E-06 Spermidine synthase
CNAG_01118 0.72 5.40E-08 Amino acid transporter
CNA08130 0.72 2.90E-08 2-hydroxyacid dehydrogenase
CNL04780 0.64 1.90E-08 Carbonic anhydrase protein
CNJ00690 0.59 1.20E-09 Uracil permease
Nucleotide metabolism CNC04630 0.71 1.80E-06 Thymidylate kinase
CNE00200 0.69 9.80E-08 Transferase purine nucleotide biosynthesis
CNJ01230 0.64 1.30E-09 Thymidylate synthase
RNA processing and modification CNF00090 0.70 7.00E-11 rRNA modification-related protein
CNE01090 0.69 6.50E-09 rRNA primary transcript binding protein
CNH02690 0.68 7.30E-08 ATP-dependent rRNA helicase (Spb4p)
CNG03270 0.66 2.70E-07 RNA-3-phosphate cyclase rRNA processing
CNJ00110 0.65 4.70E-08 rRNA (adenine-N6 ,N6-)-dimethyltransferase
Ribosome synthesis CNC05320 0.66 1.00E-10 Mitochondrial 60 s ribosomal protein l38 (yml38)
CNB01260 0.64 4.30E-09 Ribosomal large subunit biogenesis-related protein
CNB05550 0.62 5.00E-11 Cytosolic large ribosomal subunit protein
Cell division and cell cycle CNAG_06092 1.30 3.70E-07 Cyclin
CNK02970 0.72 4.00E-06 Mitotic chromosome condensation-related protein
CNAG_02267 0.72 2.00E-10 Spindle assembly checkpoint protein SLDB
CNAG_00259 0.68 2.00E-10 Bud site selection protein
Cell wall/membrane organization CNE01950 1.47 2.20E-08 UDP-N-acetylglucosamine transporter
CNA06800 0.72 1.20E-07 CAP64 gene product (Cas31p)
CNC06200 0.70 4.90E-09 Ergosterol biosynthesis-related protein
Transcriptional regulation CNAG_04457 2.02 1.30E-07 Transcription factor activity
CNAG_02877 1.60 2.40E-07 Sequence-specific DNA binding transcription factor activity
CNC02990 0.63 8.10E-08 DNA-directed RNA polymerase
CNAG_06916 0.60 1.80E-09 Zinc finger protein
Stress response CNAG_03765 1.37 6.00E-09 Trehalose-phosphatase (Tps2p)
CNA07730 1.34 2.30E-09 Multidrug resistance protein 1
CNAG_01893 1.33 2.60E-07 Glutathione S-transferase 3 (Gst3p)
CNB02790 1.30 5.60E-09 Alpha,alpha-trehalase
CNM02420 0.73 5.82E-01 Acidic laccase (Fet3p/5p)
CNF02230 0.57 2.00E-11 Glutathione S-transferase 6 (Gst6p)
*The table does not list those differential genes overlapped with Table 3.
doi:10.1371/journal.pone.0038326.t004
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(Table 3). Some deubiquitinating enzymes in Aspergillus nidulans
and S. cerevisiae also play roles in regulating their utilization of
carbon resources [58,27]. On the other hand, the growth
suppression of ubp5g mutant is associated with its decreased
proliferation rate (Figure S1), which is similar to the null mutant of
UBP15 (the orthologue of CnUBP5)i nS. cerevisiae [59]. Through
physical interaction with APC/C (anaphase-promoting complex/
cyclosome, an ubiquitin-ligation enzyme) activator Cdh1p,
ScUbp15p can reverse the degradation of cell cycle proteins via
ubiquitination and drives the transitions through the different
stages of the cell cycle [60], which then governs the rate of cell
proliferation in S. cerevisiae [61]. In C. neoformans, Ubp5 inactivation
contributed to differential transcription of several genes involved in
cell cycle regulation. Therefore we hypothesize that Ubp5 may
regulate cell division in a similar fashion in C. neoformans. The
ubp5gmutant may be dependent on such regulatory mechanisms
to reduce non-essential energy consumption and to meet enhanced
energy demand due to high temperature, since Ubp5 deletion may
disturb normal energy mobilization and utilization in C. neoformans
(Table 3).
In addition to asexual propagation, we found that Ubp5 also
plays an essential role in sexual reproduction and possibly
production of one of the primary infectious propagules (basidio-
spores) in human cryptococcosis [62]. Sexual development of
cryptococcal cells involves a series of fundamental events such as
plasmogamy, karyogamy, meiosis and sporulation [63]. Our tests
showed that the mating of ubp5D mutant with WT fails to produce
any filaments, and appears to be blocked at the point of cell fusion.
This is partially attributed to blocked MFa pheromone gene
induction during mating (Figure 5). A recent study illustrates that
the ubiquitin ligation enzyme Fbp1 also regulates sporulation in
fbp1D bilateral crosses of C. neoformans [64]. However, it remains to
be elucidated whether it works in concert with other genes such as
the DUBs. Several ubiquitin-related proteins, such as Ubi4
(polyubiquitin), Doa4, and Ubp14 (deubiquitinating enzymes)
were confirmed to function in the coordination of sexual
reproduction in S. cerevisiae, where deletions of these genes lead
to a sporulation defect [65,25]. The pathway may be dependent
on the degradation of MAPK pathway components or the
transcriptional repressor of mating-type specific genes mediated
by ubiquitination [66,67,68]. The ubiquitin pathway may also
regulate sporulation in a similar way in C. neoformans. However, no
sporulation defects have been shown in the ScUbp15 mutant as
have been observed for the C. neoformans orthologue CnUbp5. This
illustrates the functional divergence and redistribution among the
deubiquitinating enzymes from different fungal species.
C. neoformans is a globally distributed and free-living pathogenic
fungus with tenacious vitality, which is illustrated by its adaptation
to dramatically different environments during infection within a
mammalian host. Among many in vivo stressors for this yeast,
increased environmental temperature is a major challenge that C.
neoformans encounters upon initial entry into the host. We
demonstrated that disruption of the C. neoformans UBP5 gene
confered a conditional temperature-sensitive growth defect.
Reconstitution of the wild-type UBP5 allele fully restored the
ability of the ubp5D mutant to grow at 37uC. Sorbitol and trehalose
are important sugars for thermotolerance in yeasts with their
known ability to stabilize proteins, cell walls, and membranes
[69,35]. However, sorbitol did not suppress the ts phenotype of
ubp5D, and the ubp5D mutant produced WT trehalose levels (data
not shown). Therefore, the influence of Ubp5 on heat tolerance is
likely independent of the trehalose pathway. Dozens of genes and
several signaling pathways (such as MAPK, Ca
2+/calcineurin, and
Ras1 pathways) have also been identified as closely related to
thermotolerance in C. neoformans [8,70,13]. For example, several
mutants in the Ras1 pathway show a similar conditional ts
phenotype, where the mutants are viable but fail to grow at 37uC
or 39uC [71,70,72]. It remains to be proven whether Ubp5 is
connected to the Ras1 pathway in regulation of thermotolerance
in C. neoformans. Interestingly, no other deubiquitinating enzymes
in C. neoformans appear to take part in regulation of thermotoler-
ance other than Ubp5 [32]. In contrast, studies in S. cerevisiae reveal
that several DUBs such as Doa4, Ubp8, Ubp10 and Ubp15 play
roles in thermotolerance [22], and again illustrate both the
functional similarities and divergences of DUBs between these two
fungal species.
In addition to regulating thermotolerance, Ubp5 is also essential
for the resistance of C. neoformans to other important biological
stresses such as oxidative and nitrosative stress, salt stress, cell wall
and cell membrane damaging agents, and antifungal agents
(Figure 2 and Table 2). The ubiquitin-proteasome system has been
identified as one of four core protein families in response to H2O2
stress across multiple eukaryotic species, including humans, plants,
and both fission and budding yeasts [73]. A recent study
demonstrated that the ubiquitin system is involved in both
oxidative stress responses and in responses to antifungal agents
such as fluconazole and amphotericin B in C. neoformans [33].
Consistent with these general phenotypic observations, our
findings identified Ubp5 as specifically important for enhanced
susceptibility to all four classes of antifungal agents, and suggest
that a single deubquitinating enzyme may be implicated in the
regulation of ergosterol synthesis, DNA/RNA biosynthesis and b-
glucan formation in C. neoformans, which is also supported by our
transcription profiling data (Tables 2 & 3). Along with Ubp5, we
observed that the doa4D mutant also showed decreased resistance
to high sodium ions, 0.02% SDS and 0.1% caffeine, and both
doa4D and ubp13D mutants are more sensitive to fluconazole and
caspofungin, demonstrating some functional overlap of the
deubiquitinating enzymes in C. neoformans.
Presumably, various extracellular or intracellular stresses such as
high temperature, oxidative and nitrosative damage, high salt, and
antifungal drugs, lead to accumulation of misfolded or damaged
proteins inside the yeast cell, and cause cell damage that is
prevented by their removal through the ubiquitin-dependent
proteolytic pathway. The importance of ubiquitin, as an essential
element during stress responses, is further highlighted by the
requirement of a functional polyubiquitin gene to withstand heat
stress, elevated H2O2, and other stress agents in yeast [65,74,75].
Conversely, deubiquitination is not an essential pathway for
general survival. The primary function of DUB enzymes is to
maintain ubiquitin homeostasis via processing or recycling
ubiquitin from its precursors or adducts [19]. Ubiquitin is likely
encoded by two genes (UBI4 and UBI1)i nC. neoformans, which
produce a linear peptide consisting of polyubiquitin (five copies) or
monoubiquitin fused to a ribosomal protein [76]. Therefore, we
hypothesize that Ubp5 in C. neoformans may be the major
deubiquitinating enzyme to deal with stress. We suspect that it
works synergistically with Ubi4 to maintain ubiquitin homeostasis
especially under stressful conditions (Figure S3) and these specific
regulatory connections will need to be further understood.
Several studies confirm that signaling pathways, such as PKC/
MAPK, HOG, and Ca
2+/ calcineurin pathways, jointly coordi-
nate the stress responses in C. neoformans [4,77,13] and studies in
other eukaryotic species reveal that the ubiquitin-proteasome
system plays an important role in the regulation of these signaling
pathways [78,79,80,81]. For example, the ubiquitin system can
down-regulate the HOG pathway via selective degradation of the
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illustrates that the ubiquitin system may also play roles in osmotic
stress, oxidative damage, and antifungal stress pathways by
regulating the HOG pathway in C. neoformans [33]. Our
microarray data also demonstrate that Ubp5 inactivation highly
induces the transcription of several genes encoding MAPK and
Ca
2+/calcineurin signal pathway components such as MAPKKK
and CPB1. Therefore, we hypothesize that there is complicated
crosstalk between deubiquitinating enzymes and other signaling
pathways in C. neoformans that require further study to understand
their total impact on the pathobiology of C. neoformans.
In this study, we performed biological screening with both a
macrophage-killing assay and a G. mellonella infection model. These
models assess different aspects of cryptococcal pathogenesis and
allow us to examine the virulence composite differences of each
DUBmutantinabiologicalcontext(Figure6andFigure7A?B).We
found that deletions in either the UBP5 or DOA4 led to dramatic
attenuationinvirulenceinbothmodelsandtherewerenosignificant
virulence differences between ubp5D and doa4D mutants in either
model, although disruption of UBP5 did yield more altered in vitro
phenotypes under several conditions. Reduced survival in the
macrophageassayforbothubp5Danddoa4Dwasobserved,however,
the reconstituted ubp5D+UBP5 strain was unable to restore survival
for the ubp5D mutant in this assay. This result may be due to the
ectopic integration of UBP5 in this strain suggesting that precise
transcriptional control of UBP5 is required; alternatively, a
secondary mutation may exist in this strain.
Our results showing attenuated virulence of the doa4D mutant in
C. neoformans was consistent with a prior report on this mutant in the
mouse inhalation model [32]. It should be noted that the doa4D
mutantwasnotcomplementedinthispriorwork,norinthiscurrent
report.Itshouldalsobepointedoutthattheubp14Dmutant(instrain
H99) displays wild-type virulence in our assay (P=0.995) while the
samemutantinthegene-deletionlibrary(instrainCMO18)showed
decreased lung infectivity in the mouse model [32]. These
contradictory results may be attributed to differences between
vertebrate and non-vertebrate hosts, and/or the known variation of
virulence between the different parental strains.
We also used the mouse inhalation model to test the virulence of
the ubp5D mutant. All the mice infected by the ubp5D mutant
survived for 8 weeks with low burden of yeasts in lung tissue and no
viable yeast cells in CNS. With the long-term yeast survival in lung
tissue of mice without dissemination and attenuation in the room
temperatureheterologoushostmodel(G.mellonella),clearly,thermo-
tolerance is not the only virulence factor influenced by Ubp5.
C. neoformans virulence has been linked to several other well-
defined factors, including the production of capsule, melanin, and
various lytic enzymes [82,83,84]. Of these classical virulence
associated traits, capsule attachment was altered in the ubp5D
mutant (Figure 3). Interestingly, a small proportion of mutant cells
(10%) still exhibited normal capsule production although most
showed an apparent capsular defect. Capsule production is a
complex and dynamic process including intracellular polysaccha-
ride synthesis, secretion of capsular polysaccharide via vesicles,
and extracellular assembly [85]. Our capsule assay indicates that
UBP5 deletion does not affect capsule synthesis or secretion
(Figure 3D), therefore Ubp5 probably participates in the
polysaccharide assembly on the C. neoformans cell wall. Previous
studies have identified that cell wall components such as alpha (1–
3) glucan and chitin-derived molecules are required for GXM
(major capsule component) anchoring to the cell surface
[37,86,87]. In fact, enhanced susceptibility to cell wall-damaging
agents such as caspofungin in the ubp5D mutant provides indirect
evidence for its impact on cell wall formation. It has been reported
that deletion of the transcriptional regulator RIM101 produces a
similar capsule defect by altering the expression of genes
responsible for capsule attachment to the cell wall [88]. However,
we examined the transcriptional expression of AGS1 (encoding
alpha-1,3-glucan synthase, key enzyme cell wall synthesis) and no
significant differences were observed between ubp5D mutant and
WT strain. It is possible that Ubp5 may be participating in
regulation or modification of chitin-related structures or cell-wall
components other than alpha-1,3-glucan for capsule assembly,
which is also supported by our transcriptome profiling analysis in
the ubp5g mutant. On the other hand, ubiquitination and
deubiquitnation are essential post-transcriptional modifications
for many protein targets. Ubp5 may regulate the synthesis or
degradation of the proteins (including Ags1) essential for capsule
attachment at the protein translation level.
Our melanization assay did demonstrate some functional
crosstalk among deubiquitinating enzymes in C. neoformans.I n
our study, several deubiquitinating enzymes (such as Ubp5, Doa4,
Ubp13 and Ubp14) influenced pigment production in C. neoformans
by their common coordination of intracellular copper homeostasis
(Figure 4). Disruption of these genes resulted in hypomelanized
colonies of C. neoformans at 37uC, a phenotype that can be
suppressed by additional exogenous copper ions. Similar results
were reported with two other genes, CCC2 (copper transporter)
and ATX1 (copper chaperone), both of which could mediate
intracellular transport of copper ion to regulate laccase transcrip-
tion [39] . The melanin defect was not as profound in the other
DUB mutants at 37uC, and high temperature may disturb
regulation of copper metabolism. However, melanization is
impacted with the ubp5D mutant at 30uC and this may be related
to its decreased growth rate. Our results with H99 stand in
contrast to a previous study [32], where deletion of DOA4 or
UBP14 led to a melanin defect in the CMO18 strain at 30uC.
Melanization generally provides C. neoformans an added survival
advantage against both environmental predators and the mam-
malian host immune system [89,90,7]. However, disruption of
either UBP13 or UBP14 does not attenuate the virulence of C.
neoformans in both macrophage and wax moth killing assays as the
ubp5D and doa4D mutants do despite their effects on melanization.
This finding suggests that hypomelanization may not be a critical
factor for attenuated virulence in the ubp5D and doa4D mutants
and specifically, Doa4 may depend on other unrecognized
mechanisms to regulate pathogenesis in C. neoformans.
In summary, we have clearly demonstrated that deubiquitinat-
ing enzymes, especially Ubp5, are necessary for the efficient
phenotypic expression of multiple virulence factors in the model
fungal pathogen C. neoformans. These enzymes play pivotal roles in
regulating propagation, sporulation, and stress responses. Their
distinct roles further illustrate the evolutionary divergence of
certain pathogenic fungi from the model yeasts such as S. cerevisiae,
and also provide an important paradigm for further exploring the
functions and mechanisms of deubiquitinating enzymes on the
virulence of other fungal pathogens, such as Candida albicans, A.
fumigatus, Ustilago maydis, and Magnaporthe grisea. Furthermore, the
pleiotropic phenotypes of Ubp5 highlight its potential as an
antifungal drug target. Indeed, inhibitors of some deubiquitinating
enzymes including Usp7 (Ubp5’s homolog in human) are current
viable targets for anticancer therapy [91]. Therefore, we propose
that specific deubiquitinating enzyme inhibitors could provide
similar benefits in the prophylaxis and treatment of fungal diseases.
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Strains, Plasmids, and Media
The C. neoformans strains used in this study are listed in Table 1.
Strains were cultured at 30uC on YPD agar medium, and selective
media contained nourseothricin (100 mg L
21) and/or neomycin
(G418 200 mg L
21). Capsule-inducing medium, urease test
medium and DOPA were prepared as previously reported
[92,93]. Stress media were created by adding different stress-
inducing agents into YNB agar medium (0.67% yeast nitrogen
base without amino acids, 2% glucose) or YPD agar medium
before autoclaving. V8 medium (pH=5.0) was used for mating
and cell infusion assays. Medium for J774 murine macrophages
was prepared as previously reported [94].
Transcriptional Profiling
Transcriptional profiles were generated for WT and previously
described mutant strains [95] from either ex vivo CSF and serum
cultures or in vivo rabbit and human samples. In the comparison
of CSF and serum exposure, WT strain H99 was incubated in two
50 mL YPD broth cultures for 24 hours at 30uC with shaking,
washed with sterile distilled water, and resuspended in 50 mL
sterile distilled water. The cultures were then split in half and
pelleted by centrifugation, with half of the cultures resuspended in
filter-sterilized human CSF or serum from anonymous human
donors. These cultures were then incubated at 37uC with shaking,
and harvested at either 1 or 24 hours post-resuspension in each
biological fluid for RNA extraction. In the comparison of ex vivo
CSF and rabbit infection, WT strain H99 was grown as described
above, resuspended in ex vivo CSF for 24 hours, and harvested for
RNA extraction. In the comparison of rabbit and human samples,
New Zealand White rabbits were inoculated with WT strain H99
and harvested by intracisternal spinal tap on days 1 and 7 as
previously described [95]. For the human sample, RNA was
extracted from CSF obtained from a de-identified patient with
cryptococcal meningitis as previously described [96]. RNA for all
samples was obtained from lyophilized cells using the TriZol
extraction protocol (Invitrogen, Carlsbad, CA) followed by
purification using the Qiagen RNeasy kit (Qiagen, Valencia,
CA) as previously described [96].
In the comparison between ubp5g mutant and wild-type strain,
both strains were inoculated in 50 mL YPD medium and grown to
mid-log phase (OD600?1.5) at 30uC. The cultures were then split
into two parts and pelleted by centrifugation. One part of the
cultures resuspended in 25 mL fresh YPD medium and incubated
for 1 h at 37uC. Following RNA extraction, microarray hybrid-
izations and data acquisition were performed at the Duke
Microarray Facility (http://microarray.genome.duke.edu/) ac-
cording to their established protocols for custom spotted arrays.
All transcription profiling data generated for this study have been
deposited in the Gene Expression Omnibus, a MIAME-compliant
database at the National Center for Biotechnology Information,
under Accession # GSE35067.
Construction of DUB Mutant Strains and Reconstitution
Each DUB gene was disrupted in H99 and/or KN99a strains
background by overlap PCR [97]. The purified PCR fragments
were reduced to a 2 ml volume and precipitated onto 10 ml gold
microparticles (0.6 mm; Bio-Rad) for biolistic transformation [98].
Stable transformants were selected by plating cells onto YPD
medium containing either neomycin or nourseothricin. Mutants
were screened by PCR using appropriate primers (Table S1).
Positive transformants identified by PCR screening were further
confirmed by Southern blot analysis.
To complement the ubp5D mutant, a genomic DNA fragment
containing ORF, promoter and terminator region was amplified
using primers Re0104-F and Re0104-R. This PCR fragment and
the digested plasmid pCH233 by Xba I were fused with In-
FusionH EcoDry
TM Cloning System (Clontech). The reconstructed
vector pUBP5-NAT was reintroduced into ubp5D mutants via
biolistic transformation. Positive colonies were selected on YPD
agar plus nourseothricin. Reconstitution was confirmed by PCR
and Southern hybridization.
Southern Blot Analysis
The mutant and reconstituted strains were reconfirmed using
Southern hybridization analysis for gene replacement. Genomic
DNA (20 mg) was digested with proper restriction endonucleases
and separated on a 0.8% agarose gel. The DNA was transferred to
a positively charged nylon membrane (Roche Applied Science,
Indianapolis, IN). Membranes were hybridized with NEO, NAT
or target-gene digoxigenin-labeled DNA probes overnight, as
specified by the manufacturer (Roche Applied Science, Indianap-
olis, IN) washed and detected on the membrane [94]. DNA bands
of interest were visualized on film following 3 to 10 min exposures.
RNA Extraction, cDNA Synthesis and Quantitative Real-
time PCR
Following incubation to mid-log phase, 50 ml of C. neoformans
cells were harvested by centrifugation at 1,800 6g for 5 min,
washed once with 16 PBS, and lyophilized overnight. The
lyophilized pellet was then vortexed with 3 ml glass beads and
resuspended in 4 ml TRIzol Reagent (Sigma). After sitting at
room temperature for 5 min, 800 ml chloroform was added and
the mixture was shaken for 30 s. The cell lysate was then
centrifuged at 8,000 6g for 10 min, and the supernatant was
transferred to a new tube. Same volume of isopropanol was added,
incubated for 10 min at room temperature, and centrifuged at
8,0006g for 10 min. After washing the pellet with 75% ethanol, it
was diluted into 300 ml RNase-free water and incubated with
DNase I at 37uC for 1 h. The RNA was purified with RNeasy
Mini Kit (QIAGEN) again, and then stored at 280uC. First-strand
cDNA was synthesized using random hexamer primers via the
SuperScript III First-Strand Synthesis Kit for RT-PCR (Invitro-
gen) according to its protocol.
The resulting cDNA was used as template for quantitative real-
time PCR using iQ SYBR Green Supermix (Bio-Rad) according
to the manufacturer’s recommendations. Primers used for each
gene are listed in Table S1 in the supplemental material. The
multicolor real-time detection system was used with the following
PCR conditions: an initial denaturing cycle of 95uC for 3 min and
40 cycles of denaturation at 95uC for 10 s and annealing/
extension at 55uC for 20 s. Each reaction was performed in
triplicate. The constitutively expressed GPD1 gene was used to
normalize gene amplification for each strain and condition [99],
and expression (n-fold) was calculated relative to the WT strain
H99 using the Bio-Rad iCycler software system as previously
described [93].
In vitro Stress Assays
Each strain was incubated to saturation at 30uC in YPD
medium, washed, serially diluted (1 to 10
6dilutions) in 16 PBS,
and spotted (3 ml) onto YNB or YPD agar medium containing
different stress-inducing agents. For the oxidative and NO stress
test, 2 mM H2O2 and 0.75 mM NaNO2 (pH=4.0) were added
into YNB agar medium. For the osmotic stress and high salt
sensitivity test, we added 1.5 M sorbitol, 1.5 M NaCl, 1.5 M KCl
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were spotted onto YPD agar media containing 0.02% SDS, 0.1%
caffeine and 0.5% congo red. Then spotted cells were incubated at
30uC for 5 days and photographed.
All the mutant strains, along with WT, were analyzed for their
sensitivities to the stress of antifungal compounds, such as
amphotericin B, fluconazole, flucytosine and caspofungin. Tests
were performed in accordance with NCCLS protocol M-27A [35],
and Candida parapsilosis ATCC22019 was used as a quality control
strain. The MIC80 was determined to compare the antifungal
activity among different strains.
Assays for Melanization, Urease, Capsule Production
For the melanization test, cells were spotted onto L-DOPA agar
and incubated for 3–7 days at 30uC and 37uC. Melanin
production was monitored and photographed. For urease assay,
strains were streaked onto Christiansen’s urea agar at 30uC for 24
hours and checked for the color change with WT and ure1D strains
as controls [92].
For capsule production, different C. neoformans strains were
incubated into DME medium or low iron medium at 37uCi n5 %
CO2 for 3 days in tissue culture flasks. Following capsule
induction, the cells were washed once with 16 PBS, and
resuspended in 1 ml sterile PBS for visualization of capsule. Each
strain was mixed with India ink preparations on glass slides for
visualization. Images were collected at a 1006 magnification.
Total (cell and capsule) and cell-only diameters were compared for
50 cells for each strain. Cryptocrit was also used to measure
differences in capsule [93]. In order to examine the capsule
secretion, a capsule transfer assay was performed per previous
studies [37]. Briefly, conditioned medium (CM) was prepared as a
source of capsule polysaccharide by growing WT and ubp5D
mutant cells in DMEM medium for one week while CM from
acapsular cells (cap59D) as a negative control, after which 2.5610
6
of acapsular acceptor cells (cap59D) were incubated in the CM
media. For indirect immunofluorescence, cells were co-cultured
for one hour with monoclonal antibody mAb18B7 and then
combined with secondary antibody (Alexa Fluror anti-mouse IgG
2m gm l
21, Invitrogen). Cells were visualized on a Zeiss LSM
inverted confocal microscope with the Argon/2 488 laser at
1006magnification.
Mating and Cell Fusion Assays
In a mating assay, strains of opposite mating type were mixed
and co-cultured on V8 agar medium at 25uC in the dark. Mating
filaments and basidiospore formation were examined and record-
ed by photography using a Zeiss Axio Imager A1 fluorescent
microscope equipped with an AxioCam MRM digital camera
after two weeks. Also, a cell fusion assay was performed [100]. 10
7
cells ml
21 of each mutant containing Nat
R or Neo
R markers
(DF001 and DF002) were mixed together in an equal volume and
5 ml of the mixture was spotted onto V8 medium and incubated
for 24 h at 25uC in the dark. Scraped cells from the V8 medium,
were resuspended in 1 ml dH2O, and then 200 ml of cell
suspension were spread onto YPD medium containing nourseo-
thricin and neomycin. The numbers of colonies on each plate were
counted after 4 days of incubation at room temperature. TOC4
(Neo
r wild-type strain) and DF010 (Nat
r wild-type strain) were
used as control strains.
Macrophage Killing Assays
We assessed ubp5D mutant and its complemented strains for
survival within macrophages. Yeast strains were incubated
overnight at 30uC. J774A.1 macrophages at a concentration of
10
6 per well were activated by gamma interferon-c and
lipopolysaccharide, then inoculated with yeasts for the macro-
phage-yeast survival assay [94]. Briefly, activated macrophages
were coincubated with 10
6 yeast cells of each strain for 2 h at 37uC
in 5% CO2 to allow phagocytosis. Prior to co-incubation, cells of
each yeast strain were incubated with the monoclonal antibody
mAb18B7 for one hour. Then extracellular yeasts were washed
away three times with 16PBS and the monolayers were incubated
in DMEM. For the macrophage-yeast killing assay, washed
monolayer cells containing yeast and macrophage cells were co-
incubated overnight (24 hr). Macrophages were then lysed with
0.5% SDS, and lysates were diluted and plated on YPD to count
numbers of viable yeasts present following incubation at 30uC for
3 days.
Galleria Mellonella Virulence Assay
G. mellonella caterpillars (330625 mg in body weight) in the final
instar larval stage were employed in our assays. Sixteen caterpillars
of the required weight were randomly chosen in each group. A
10 ul Hamilton syringe was used to inject 10 ul aliquots of the
yeast inoculum (5610
5 cells) into the hemocoel of each caterpillar
via the last left proleg as described previously [52], and these
caterpillars were incubated in plastic containers at room temper-
ature. Caterpillars were considered dead when they displayed no
movement in response to touch. The number of dead caterpillars
was recorded daily. Each assay was performed in duplicate.
Murine Virulence Assay
Virulence of the ubp5D mutant strain was assessed in the
inhalational mouse model according to an established protocol [9].
A/Jcr mice (10 mice for each C. neoformans strain) were infected
intranasally with 10
5 CFU of either WT (H99), mutant (ubp5D), or
reconstituted (ubp5D+ UBP5) strains of C. neoformans in a volume of
50 ml sterile PBS. The mice were monitored closely for signs of
worsening infection and euthanized at predetermined endpoints
(weight loss of $15%, neurological symptoms, and an inability to
access food/water).
Statistics
Data from the survival assays in both G. mellonella and murine
infection models were plotted using Kaplan-Meier survival curves
and analyzed by the log rank test (SPSS 15.0). All the other
statistical data were calculated and compared using (Student t
tests). P,0.05 were considered statistically significant.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of Duke University (Protocol Number: A266-08-10).
Infections were carried out under isofluorane anesthesia, and all
efforts were made to minimize suffering.
Supporting Information
Figure S1 Growth rate measurement for the ubp5D
mutant. WT, ubp5D and ubp5D+UBP5 strains were grown
overnight at 30uC in liquid YPD medium. Cell numbers were
counted by hemacytometer. 10
6 CFU from each culture were
transferred to 30 ml fresh YPD medium in flasks and incubated at
30uC. OD600 was measured for each culture at four hour intervals.
Mutant ubp5D showed slower growth than H99 at 30uC.
(TIF)
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Christensen’s medium at 30uC for the detection of urease
production. ure1D mutant strain was used as a negative control.
(TIF)
Figure S3 UBP5 deletion lead to increased expression of
UBI4 in C. neoformans. Expression of polyubiquitin gene UBI4
at (A) 30uC and (B) 37uC. UBI4 was up-regulated in ubp5D mutant
while the reconstituted strain showed similar expression level like
WT strain. And high temperature exposure reinforced the up-
regulation of UBI4 expression in ubp5D strain.
(TIF)
Table S1 Primers used in this study. Primers were
designed using the Primer3 software package (http://frodo.wi.
mit.edu/primer3/) for generating gene-deletion cassettes, gene-
reconstitution cassettes, Southern hybridization probes, or real-
time PCR products.
(PDF)
Table S2 Ubiquitin-proteasome genes identified by in
vivo transcription profiling. Transcription profiles of in vivo
C. neoformans cells from human or rabbit infections was compared
to profiles from C. neoformans cells grown ex vivo in either pooled
human cerebrospinal fluid or serum to identify genes that are
differentially expressed in the host.
(PDF)
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